Kryptos Biotechnologies provides innovative life science systems that reveal the complexity of biology for clinicians and scientists.
Kryptos Biotechnologies has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Kryptos Biotechnologies's investors include SkyDeck Berkeley, Coolidge Corner Investment, LG Chem, FuturePlay, Osang Healthcare.
Kryptos Biotechnologies is headquartered in Hayward, United States.
Kryptos Biotechnologies provides innovative life science systems that reveal the complexity of biology for clinicians and scientists.
Kryptos Biotechnologies is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Kryptos Biotechnologies — Funding & Investors." VCBacked, March 28, 2024, https://www.vcbacked.co/company/kryptos-biotechnologies. Accessed July 27, 2026.
VCBacked. (2024). Kryptos Biotechnologies — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/kryptos-biotechnologies
{{cite web |title=Kryptos Biotechnologies — Funding & Investors |url=https://www.vcbacked.co/company/kryptos-biotechnologies |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated